Dhinakaran Rajagopal

Dhinakaran Rajagopal

Active Director Cfo DIN 09115326
DIN 09115326 First appointment Mar 2021 Primary industry Agriculture
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Total affiliations 4 Since Mar 2021
Shareholding value •••• Premium profile

About Dhinakaran Rajagopal

Data last updated:

Dhinakaran Rajagopal is a Cfo at Indrayani Biotech Limited (since 2025), Additional Director at Vaasan Medical Center (India) Private Limited (since 2023) and Director at Fine Mart Private Limited (since 2021), and holds 1 more current directorship. The companies operate in Agriculture, Healthcare and Trading. The 3 current companies with reported revenue have a combined latest revenue of ₹228 Cr; the largest is Indrayani Biotech Limited at ₹167 Cr (FY 2024).

DIN 09115326
Primary Designation Cfo
Industry Agriculture
First Appointment 15 Mar 2021
Oldest Company Age 34 yrs
Largest company Indrayani Biotech Limited · ₹167 Cr (FY 2024)
Combined revenue ₹228 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indrayani Biotech Limited L40100TN1992PLC129301
Cfo03 Apr 20251992₹167 Cr (FY 2024)Active
Additional Director25 Aug 20232010₹56.75 Cr (FY 2020)Active
Fine Mart Private Limited U51109TN2014PTC097536
Director15 Mar 20212014₹3.72 Cr (FY 2017)Active
Designated Partner17 Feb 20252022Active

Directorship timeline

Open interactive timeline →
Fine Mart Private Limited
Indrayani Biotech Limited
Ibl Laksha Hospitals Llp
Vaasan Medical Center (India) Private Limited
Premium access

Shareholding and investment profile for Dhinakaran Rajagopal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dhinakaran Rajagopal

Dhinakaran Rajagopal currently holds 4 directorships: Indrayani Biotech Limited (Cfo, since 03 Apr 2025, revenue ₹167 Cr (FY 2024)); Vaasan Medical Center (India) Private Limited (Additional Director, since 25 Aug 2023, revenue ₹56.75 Cr (FY 2020)); Fine Mart Private Limited (Director, since 15 Mar 2021, revenue ₹3.72 Cr (FY 2017)); Ibl Laksha Hospitals Llp (Designated Partner, since 17 Feb 2025).

Dhinakaran Rajagopal was first appointed on 15 Mar 2021 as Director at Fine Mart Private Limited. The most recent appointment on record is 03 Apr 2025 at Indrayani Biotech Limited.

The 3 current companies of Dhinakaran Rajagopal that report revenue have a combined latest revenue of ₹228 Cr: Indrayani Biotech Limited ₹167 Cr (FY 2024); Vaasan Medical Center (India) Private Limited ₹56.75 Cr (FY 2020); Fine Mart Private Limited ₹3.72 Cr (FY 2017).

The current boards of Dhinakaran Rajagopal's companies include Bokara Nagarajan Padmaja Priyadarshini (Indrayani Biotech Limited), Kannimangalam Subramanyan Vaidyanathan (Indrayani Biotech Limited), Kasiraman Sayee Sundar (Indrayani Biotech Limited), Kunisetty Venkateswararao (Indrayani Biotech Limited), Muthukrishnan Ramesh (Indrayani Biotech Limited), Nangavaram Mahadevan Ranganathan (Indrayani Biotech Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available